Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years old and has a huge impact on patients and society as a whole. Our understanding of AMD has developed in tandem with continued advancements in genomics, cell biology, and diagnostic technologies. These are shedding light on the underlying causes of AMD and have led to new drugs with the potential to dramatically improve the symptomatic outlook for patients. 

In Age-Related Macular Degeneration – State of the Art, the Editors have selected and edited contributions from key authors in the field of AMD, bringing the differing strands of AMD-related research into perspective – including genetics, the role of imaging modalities, and new treatment options, such as siRNA and VEGF antibodies. Age-Related Macular Degeneration is a valuable resource that will provide ophthalmologists and clinicians with a clear insight into the contemporary field of AMD and what lies just over the horizon.